JABFM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Rapid Responses: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Incretin Mimetics and DPP-IV Inhibitors: New Paradigms for the Treatment of Type 2 Diabetes
J Am Board Fam Med Hinnen et al. 19: 612

Disclosure Statements

Disclosure statements for: Incretin Mimetics and DPP-IV Inhibitors: New Paradigms for the Treatment of Type 2 Diabetes Deborah Hinnen, Loretta L. Nielsen, Amy Waninger, and Pamela Kushner J Am Board Fam Med 2006 19: 612-620

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Rapid Responses: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal

HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS